Skip to main content

Table 1 Clinicopathological characteristics of 118 patients enrolled in the present investigation

From: The role of CXC-chemokine receptor CXCR2 and suppressor of cytokine signaling-3 (SOCS-3) in renal cell carcinoma

  Number of patients (%)
Gender  
Female 31 (26.3%)
Male 87 (73.8%)
Histological type  
Clear cell RCC 99 (83.9%)
Papillary RCC 9 (7.63%)
Chromophobe RCC 5 (4.24%)
Other* 5 (4.24%)
Histological grade (Fuhrman)  
I 6 (5.08%)
II 46 (38.98%)
III 48 (40.68%)
IV 18 (15.25%)
Stage  
I 28 (23.73%)
II 15 (12.71%)
III 24 (20.34%)
IV 39 (33.05%)
Not available 12 (10.17%)
Lymph node metastasis  
No 73 (61.8%)
Yes 20 (17%)
Not available 25 (21.2%)
Total number of metastases  
Absence 30 (25.42%)
1 25 (21.19%
2 24 (20.34%)
3 11 (9.32%)
4 4 (3.39%)
Not available 24 (20.24%)
Disease progression  
Absence 19 (16.10%)
Presence 42 (35.60%)
Not available 57 (48.30%)
Follow-up  
Alive/censored 43 (45.74%) Follow-up: 49 months (6-108.8 months)
Dead of disease 51 (54.26%) Follow-up: 30.37 months (1.77-117.43 months)
  Median (range)
Age 61 (30-80)
  1. *Other histological types include collecting duct carcinoma (1 case), unclassified carcinoma (1 case), Chromophobe carcinoma with oncocytoma (1 case) and multilocular cystic carcinoma (2 cases).